Blood-Cleansing Method Tested as Cancer Vaccine – Insight from Swiss Medical Network’s Lana Kandalaft
A pioneering approach in immunotherapy is entering clinical trials: a blood-cleansing method, originally designed to remove tumor cells, is now being tested as a vaccine against cancer. The goal is to stimulate the immune system to recognize and attack tumors more effectively.
Prof. Lana Kandalaft, Chief of Clinical & Translational Research at Swiss Medical Network, is cited as an expert in cancer immunotherapy and translational research, bringing valuable insight into innovative treatment strategies.
The phase-I study involves patients with advanced ovarian cancer, representing an important step toward next-generation immunotherapies.
